Secondary Logo

Journal Logo

April 2016 - Volume 36 - Issue 2
pp: 109-193

Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study

Nasser, Azmi F.; Henderson, David C.; Fava, Maurizio; More

Journal of Clinical Psychopharmacology. 36(2):130-140, April 2016.

Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders

Sukasem, Chonlaphat; Hongkaew, Yaowaluck; Ngamsamut, Nattawat; More

Journal of Clinical Psychopharmacology. 36(2):141-146, April 2016.